Premium
(MM) (DNDN)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
-- Conference Call to be Hosted Today at 4:30 p.m. ET -- SEATTLE, Feb. 22 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today reported results for the year and quarter ended...
SEATTLE, Feb. 11 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) management will host a conference call on Monday, February 22, 2010 at 4:30 p.m. ET to review fourth quarter and...
SEATTLE, Feb. 3 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the 12th Annual BIO CEO and Investor Conference in New York City on...
SEATTLE, Jan. 5 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco...
SEATTLE, Dec. 11 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that the underwriters of its previously announced public offering have exercised in full their...
SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that it has priced its underwritten public offering of 15,000,000 shares of its common stock at a...
- Seasoned Global Oncology Executive Joining Team, Expanding Company's Commercial Expertise - SEATTLE, Dec. 10 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that...
SEATTLE, Dec. 8 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) announced today that it has commenced an underwritten public offering, subject to market and other conditions, of...
SEATTLE, Nov. 25 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that management will present at the following two investor conferences next month. NASDAQ OMX 23rd...
-- PDUFA Date Assigned as May 1, 2010 -- SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN) today announced that the U.S. Food and Drug Administration (FDA) provided...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 731,1M |
| NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,5M |
| RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 341,8M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 237,15M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,44M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
